IMMUNOGEN INC Business Finance Contracts & Agreements
32 Contracts & Agreements
- Exchange Agreements (3 contracts)
- Indenture Agreements (1)
- Note Agreements (1)
- Purchase Agreements (3)
- Share Agreements (1)
- Stock Agreements (13)
- Underwriting Agreements (8)
- Warrant Agreements (2)
- Underwriting Agreement dated May 4, 2023 by and among ImmunoGen, Inc. and Jefferies LLC, Goldman Sachs & Co. LLC and Guggenheim Securities, LLC, as representatives of the several... (Filed With SEC on May 5, 2023)
- Exchange Agreement, dated May 1, 2023, by and among ImmunoGen, Inc. and RA Capital Healthcare Fund, L.P (Filed With SEC on May 2, 2023)
- Form of Restricted Stock Unit Agreement (Inducement Plan), as amended February 3, 2023 (Filed With SEC on March 1, 2023)
- 2004 Non-Employee Director Compensation and Deferred Stock Unit Plan, as amended and restated on December 15, 2022 (Filed With SEC on March 1, 2023)
- Form of Restricted Stock Unit Agreement for Non-Employee Directors as of December 15, 2022 (Filed With SEC on March 1, 2023)
- Form of Non-Qualified Stock Option Agreement for Non-Employee Directors, as amended December 15, 2022 (Filed With SEC on March 1, 2023)
- Form of Restricted Stock Unit Agreement under the 2018 Plan, as amended February 3, 2023 (Filed With SEC on March 1, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on December 3, 2021)
- Underwriting Agreement dated December 1, 2021 by and among ImmunoGen, Inc. and Jefferies LLC and Cowen and Company, LLC, as representatives of the several underwriters named in... (Filed With SEC on December 3, 2021)
- Securities Purchase Agreement dated August 11, 2021 between ImmunoGen, Inc. and RA Capital Healthcare Fund, L.P (Filed With SEC on August 12, 2021)
- Form of Pre-Funded Warrant (Filed With SEC on August 12, 2021)
- Underwriting Agreement dated January 22, 2020 by and among ImmunoGen, Inc. and Jefferies LLC, Cowen and Company, LLC and William Blair & Company, L.L.C., as representatives of the... (Filed With SEC on January 23, 2020)
- Employee Stock Purchase Plan, as amended through September 27, 2019 (Filed With SEC on November 5, 2019)
- Royalty Purchase Agreement dated as of January 8, 2019 among the Registrant, Hurricane, LLC, Immunity Royalty Holdings, L.P., and OMERS IP Healthcare Holdings Limited (Filed With SEC on March 1, 2019)
- Employee Stock Purchase Plan (Filed With SEC on June 22, 2018)
- Underwriting Agreement dated June 6, 2018 by and among ImmunoGen, Inc. and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Cowen and Company LLC, as representatives of the... (Filed With SEC on June 7, 2018)
- Underwriting Agreement dated October 5, 2017 by and among ImmunoGen, Inc. and Jefferies LLC, Leerink Partners LLC, RBC Capital Markets, LLC, as representatives of the several... (Filed With SEC on October 6, 2017)
- Form of Exchange Agreement (Filed With SEC on September 26, 2017)
- Form of Exchange Agreement (Filed With SEC on September 1, 2017)
- RESTRICTED STOCK AGREEMENT IMMUNOGEN, INC. (Filed With SEC on August 4, 2017)
- EXCLUSIVE LICENSE AND ASSET PURCHASE AGREEMENT (Filed With SEC on August 4, 2017)
- J.P. MORGAN SECURITIES LLC PURCHASE AGREEMENT IMMUNOGEN, INC. 4.50% Convertible Senior Notes due 2021 Purchase Agreement (Filed With SEC on June 20, 2016)
- ImmunoGen, Inc. (Company) Wilmington Trust, National Association (Trustee) 4.50% Convertible Senior Notes due 2021 INDENTURE Dated as of June 20, 2016 (Filed With SEC on June 20, 2016)
- IMMUNOGEN, INC. AMENDMENT TO STOCK OPTION AGREEMENTS (Filed With SEC on May 4, 2016)
- ImmunoGen, Inc. 6,250,000 Shares of Common Stock, par value $0.01 per share Underwriting Agreement (Filed With SEC on July 12, 2012)
- ImmunoGen, Inc. 7,000,000 Shares of Common Stock, par value $0.01 per share Underwriting Agreement (Filed With SEC on May 20, 2011)
- ImmunoGen, Inc. 9,000,000 Shares of Common Stock, par value $0.01 per share UnderwritingAgreement (Filed With SEC on May 7, 2010)
- IMMUNOGEN, INC. 2004NON-EMPLOYEE DIRECTOR COMPENSATION ANDDEFERRED SHARE UNIT PLAN (asamended through September 16, 2009) (Filed With SEC on November 4, 2009)
- 5,000,000 Shares ImmunoGen, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 18, 2009)
- IMMUNOGEN, INC. AMENDMENT TO STOCK OPTION AGREEMENTS (Filed With SEC on October 31, 2008)
- NON-QUALIFIED STOCK OPTION AGREEMENT IMMUNOGEN, INC. (Filed With SEC on February 7, 2006)
- IMMUNOGEN, INC. RESTATED STOCK OPTION PLAN (as amended through February 1, 2006) (Filed With SEC on February 7, 2006)
